|
⚲
|
| Keyboard |
| Allouche Cyril
✚
|
|
|---|---|
| CIK # | 0001744573 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001744573] | |
| 4 | [0001744573] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Revance Therapeutics Inc | |
| Allouche Cyril |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Revance Therapeutics Inc RVNC
Common Stock
|
2019-03-18 | Sell | 498 | $15.48 | 7,709 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2019-03-15 | Tax withheld | 252 | $15.45 | 3,893 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2019-01-24 | Grant | 3,150 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Employee Stock Option (Right to Buy) · derivative
|
2019-01-24 | Grant | 6,500 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2019-01-22 | Option exercise | 625 | $13.35 | 8,344 |
|
Revance Therapeutics Inc RVNC
Employee Stock Option (Right to Buy) · derivative
|
2019-01-22 | Option exercise | 625 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2019-01-22 | Sell | 625 | $17.77 | 11,106 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2019-01-03 | Sell | 375 | $19.48 | 7,305 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2018-12-31 | Other | 375 | $17.11 | 6,416 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2018-11-20 | Sell | 491 | $20.66 | 10,144 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2018-11-15 | Tax withheld | 259 | $20.99 | 5,436 |
|
Revance Therapeutics Inc RVNC
Employee Stock Option (Right to Buy) · derivative
|
2018-11-09 | Option exercise | 2,188 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2018-11-09 | Option exercise | 2,188 | $13.35 | 29,210 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2018-11-09 | Sell | 2,188 | $23.72 | 51,899 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2018-07-06 | Sell | 393 | $28.35 | 11,142 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2018-06-29 | Other | 393 | $23.33 | 9,169 |
|
Revance Therapeutics Inc RVNC
Employee Stock Option (Right to Buy) · derivative
|
2018-06-20 | Grant | 9,500 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2018-06-20 | Grant | 250 | $0.00 |